| Literature DB >> 34181180 |
James Lachaud1, Cilia Mejia-Lancheros2, Anna Durbin2,3, Rosane Nisenbaum2,4, Ri Wang2, Patricia O'Campo2,5, Vicky Stergiopoulos2,3,6, Stephen W Hwang2,7.
Abstract
We assessed the effects of the Toronto Site Housing First (HF) intervention on hospitalizations and emergency department (ED) visits among homeless adults with mental illness over 7 years of follow-up. The Toronto Site is part of an unblinded multi-site randomized pragmatic trial of HF for homeless adults with mental illness in Canada, which followed participants up to 7 years. Five hundred seventy-five participants were recruited and classified as having high (HN) or moderate need (MN) for mental health support services. Each group was randomized into intervention (HF) and treatment as usual groups, and 567 (98.6%) consented to link their data to health administrative databases. HF participants received a monthly rent supplement of $600 (Canadian) and assertive community treatment (ACT) support or intensive care management (ICM) support based on need level. Treatment as usual (TAU) participants had access to social, housing, and health services generally available in the community. Outcomes included all-cause and mental health-specific hospitalization, number of days in hospital, and ED visit. We used GEE models to estimate ratio of rate ratios (RRR). The results showed HF with ACT had no significant effect on hospitalization rates among HN participants, but reduced the number of days in hospital (RRR = 0.32, 95% CI 0.16-0.63) and number of ED visits (RRR = 0.57, 95% CI 0.34-0.95). HF with ICM resulted in an increase in the number of hospitalizations (RRR = 1.69, 95% CI 1.09-2.60) and ED visit rates (RRR = 1.42, 95% CI 1.01-2.01) but had no effect in days in hospital for MN participants. Addressing the health needs of this population and reducing acute care utilization remain system priorities. Trial registration: http://www.isrctn.com/identifier: ISRCTN42520374.Entities:
Keywords: Emergency department visit; Homeless persons; Hospitalization; Housing First; Mental illness
Mesh:
Year: 2021 PMID: 34181180 PMCID: PMC8382791 DOI: 10.1007/s11524-021-00550-1
Source DB: PubMed Journal: J Urban Health ISSN: 1099-3460 Impact factor: 3.671
Fig. 1Study flowchart. *Referrals were kept for a period of up to 3 months. During the early phases of the study, there were more referrals than staff available to accept new participants; therefore, many referrals were delayed beyond the 3-month period and were excluded prior to screening
Baseline Socioeconomic characteristics of study participants with linked administrative data, by level of need and treatment group
| High Needs | Moderate Needs | |||||||
|---|---|---|---|---|---|---|---|---|
| HF | TAU | HF | TAU | |||||
| n | % or | % or | n | % or | % or | |||
| Demographics | ||||||||
| Age (years) | 180 | 37.67±11.06 | 41.45±12.03 | 0.030 | 347 | 39.56±11.60 | 40.79±12.51 | 0.345 |
| Gender, self-reported | ||||||||
| Male | 129 | 57 (65.5%) | 72 (77.4%) | 0.042 | 234 | 131 (67.9%) | 103 (66.9%) | 0.931 |
| Femalea | 49 | 30 (34.5%) | 21 (22.6%) | 113 | 62 (32.1%) | 51 (33.1%) | ||
| Self-Identified ethno-racial group (self-reported) | ||||||||
| Others | 43 | 18 (20.7%) | 25 (26.9%) | 0.451 | 120 | 66 (34.2%) | 54 (35.1%) | 0.068 |
| Black | 55 | 30 (34.5%) | 25 (26.9%) | 115 | 73 (37.8%) | 42 (27.3%) | ||
| White | 82 | 39 (44.8%) | 43 (46.2%) | 112 | 54 (28.0%) | 58 (37.7%) | ||
| Socioeconomic factors | ||||||||
| Marital status | ||||||||
| Single | 127 | 65 (74.7%) | 62 (66.7%) | 0.428 | 231 | 128 (66.3%) | 103 (66.9%) | 0.883 |
| Other | 43 | 19 (21.8%) | 24 (25.9%) | 112 | 63 (32.6%) | 49 (31.8%) | ||
| Education | ||||||||
| Less than high school | 82 | 41 (47.1%) | 41 (44.1%) | 0.566 | 164 | 98 (50.8%) | 66 (42.9%) | 0.328 |
| Completed high school | 33 | 15 (17.2%) | 18 (19.4%) | 63 | 31 (16.1%) | 32 (20.8%) | ||
| Some post-secondary school | 51 | 29 (33.3%) | 22 (23.7%) | 112 | 61 (31.6%) | 51 (33.1%) | ||
| Homelessness during lifetime (years) | ||||||||
| <3 years | 65 | 35 (40.2%) | 30 (32.3%) | 0.543 | 171 | 97 (50.3%) | 74 (48.1%) | 0.663 |
| ≥3years | 104 | 51 (58.6%) | 53 (57.0%) | 171 | 93 (48.2%) | 78 (50.6%) | ||
a= Includes seven transsexual or transgender participants
Mental health disorders of study participants with linked administrative data, by level of need and treatment group at baseline
| High Needs | Moderate Needs | |||||||
|---|---|---|---|---|---|---|---|---|
| HF | TAU | HF | TAU | |||||
| n | % or mean ± SD | % or mean ± SD | n | % or mean ± SD | % or mean ± SD | |||
| Mental health and substance usea | ||||||||
| Major depressive episode | ||||||||
| No | 148 | 72 (82.8%) | 76 (81.7%) | 0.856 | 192 | 106 (54.9%) | 86 (55.8%) | 0.864 |
| Yes | 32 | 15 (17.2%) | 17 (18.3%) | 155 | 87 (45.1%) | 68 (44.2%) | ||
| Manic or hypomanic episode | ||||||||
| No | 163 | 76 (87.4%) | 87 (93.5%) | 0.156 | 309 | 171 (88.6%) | 138 (89.6%) | 0.765 |
| Yes | 17 | 11 (12.6%) | 6 (6.5%) | 38 | 22 (11.4%) | 16 (10.4%) | ||
| Post-traumatic stress disorder | ||||||||
| No | 157 | 74 (85.1%) | 83 (89.2%) | 0.400 | 250 | 137 (71.0%) | 113 (73.4%) | 0.622 |
| Yes | 23 | 13 (14.9%) | 10 (10.8%) | 97 | 56 (29.0%) | 41 (26.6%) | ||
| Panic disorder | ||||||||
| No | 172 | 82 (94.3%) | 90 (96.8%) | 0.412 | 281 | 157 (81.3%) | 124 (80.5%) | 0.845 |
| Yes | 8 | 1 to 5 (0.6 to 5.8%)b | 1 to 5 (1.1% to 5.5%)b | 66 | 36 (18.7%) | 30 (19.5%) | ||
| Mood disorder with psychotic features | ||||||||
| No | 134 | 65 (74.7%) | 69 (74.2%) | 0.936 | 282 | 158 (81.9%) | 124 (80.5%) | 0.750 |
| Yes | 46 | 22 (25.3%) | 24 (25.8%) | 65 | 35 (18.1%) | 30 (19.5%) | ||
| Psychotic disorder | ||||||||
| No | 74 | 37 (42.5%) | 37 (39.8%) | 0.709 | 260 | 145 (75.1%) | 115 (74.7%) | 0.923 |
| Yes | 106 | 50 (57.5%) | 56 (60.2%) | 87 | 48 (24.9%) | 39 (25.3%) | ||
| Substance use disorder | ||||||||
| No | 161 | 75 (86.2%) | 86 (92.5%) | 0.172 | 318 | 175 (90.7%) | 143 (92.9%) | 0.465 |
| Yes | 19 | 12 (13.8%) | 7 (7.5%) | 29 | 18 (9.3%) | 11 (7.1%) | ||
| Alcohol abuse | ||||||||
| No | 148 | 70 (80.5%) | 78 (83.9%) | 0.550 | 304 | 165 (85.5%) | 139 (90.3%) | 0.181 |
| Yes | 32 | 17 (19.5%) | 15 (16.1%) | 43 | 28 (14.5%) | 15 (9.7%) | ||
a= Based on the DSM-IV criteria using the Mini International Neuropsychiatric Interview [MINI] version 6.0, c=Absolute numbers less than six have been suppressed to reduce the risk of identification
Treatment and time interaction results from models comparing each post-randomization period with 1 year pre-randomization
| Outcome | Randomization groups | 0 to 2 years post-randomization vs | 2 to 7 years post-randomization vs | 0 to 7 years post-randomization vs |
|---|---|---|---|---|
| 1 year pre-randomization | 1 year pre-randomization | 1 year pre-randomization | ||
| Ratio of rate ratios (95%CI) | Ratio of rate ratios (95%CI) | Ratio of rate ratios (95%CI) | ||
| All Interventions vs. All Treatment as Usual | 0.98 (0.72-1.33) | 1.32 (0.95-1.84) | 1.15 (0.85-1.56) | |
| HN-HF vs. TAU | 0.70 (0.45-1.07) | 0.89 (0.52-1.52) | 0.83 (0.52-1.35) | |
| MN-HF vs. TAU | 1.31 (0.82-2.10) | 1.40 (0.92-2.13) | ||
| All Interventions vs. All Treatment as Usual | 1.10 (0.79-1.52) | 1.20 (0.81-1.76) | 1.16 (0.83-1.62) | |
| HN-HF vs. TAU | 0.69 (0.45-1.04) | 0.87 (0.49-1.55) | 0.80 (0.49-1.30) | |
| MN-HF vs. TAU | ||||
| All Interventions vs. All Treatment as Usual | 1.06 (0.75-1.50) | 1.28 (0.88-1.87) | 1.15 (0.83-1.60) | |
| HN-HF vs. TAU | 0.72 (0.46-1.15) | 0.82 (0.47-1.45) | 0.71 (0.44-1.16) | |
| MN-HF vs. TAU | 1.61 (0.91-2.86) | |||
| All Interventions vs. All Treatment as Usual | 1.08 (0.72-1.63) | 1.13 (0.71-1.80) | 1.11 (0.74-1.65) | |
| HN-HF vs. TAU | 0.62 (0.37-1.04) | 0.77 (0.41-1.45) | 0.71 (0.42-1.22) | |
| MN-HF vs. TAU | 1.79 (0.95-3.38) | |||
| All Interventions vs. All Treatment as Usual | 0.62 (0.38-1.03) | |||
| HN-HF vs. TAU | ||||
| MN-HF vs. TAU | 1.81 (0.96-3.39) | 0.99 (0.43-2.29) | 1.29 (0.63-2.65) | |
| All Interventions vs. All Treatment as Usual | 1.02 (0.78-1.34) | 1.26 (0.95-1.65) | 1.10 (0.82-1.48) | |
| HN-HF vs. TAU | 0.63 (0.39-1.03) | 0.75 (0.44-1.27) | 0.57 (0.31-1.03) | |
| MN-HF vs. TAU | 1.29 (0.92-1.80) | |||
| All Interventions vs. All Treatment as Usual | 0.89 (0.65-1.22) | 0.82 (0.52-1.29) | 0.84 (0.60-1.19) | |
| HN-HF vs. TAU | 0.75 (0.44-1.26) | |||
| MN-HF vs. TAU | 1.12 (0.81-1.53) | 1.36 (0.99-1.88) |
Bold means “statistically significant at a level of 5%”